Venture Capital Intelligence
Search by what an investor has done, not what its website says
Every organization here entered through a public record: a Form ADV filing that claims the venture capital fund adviser exemption or reports venture funds, a Form D venture vehicle, a portfolio page, or a cited announcement. The class chip says what kind of organization it is and how sure we are; the profile says why. Candidates are shown as candidates and are not counted as coverage.
venture manager, reported GAV $186M across 2 vehicles
venture manager, reported GAV $1,006M across 22 vehicles
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
High-conviction seed partners to founders transforming critical industries. $100M invested in 72 companies building AI, robotics, and enterprise infrastructure.
Building deep tech companies powered by material science.
venture manager, reported GAV $610M across 12 vehicles
venture manager, reported GAV $1,001M across 69 vehicles
registered adviser; venture funds are 0% of 42 private funds
both early and growth/opportunity families, reported GAV $95M
U••••••••• VC is a Boston-based venture capital firm backing bold early-stage B2B software founders at Pre-Seed and Seed.
W•••••• Capital is an industry leading private holding firm that partners and invests in growing private businesses and their management teams.
S•••••• T••••••••• is a venture capital platform funding the next generation of companies solving built environment challenges.
B•••••• Global Advisors provides investment solutions and family office services for venture capital and private equity executives.
corporate parent: Blackstone Inc.
Series A investor in fast-scaling B2B AI, software, fintech, and hardware startups.
no venture fund on Form ADV; public LPs book its vehicles as Growth Equity
registered adviser; venture funds are 24% of 15 private funds
A•••••••• Capital™ is a global growth equity investor with $1 billion AUM that focuses on growth-stage companies in AI, data infra, cybersecurity, etc. Founded in 2018, the firm employs a distinctive, highly research-driven approach. Headquartered in Boston, with investment teams in NYC and San Francisco, A•••••••• Capital™ partners with category-defining entrepreneurs to shape the future.
Explore the L••••••• portfolio and learn about the financial services, employee programs, and strategies of our top-rated hospitality management company.
corporate parent: the Ag
G•••••••• G••••• Equity is a Boston-based firm with years of operating and functional experience partnering with growth-stage companies using technology to transform industries.
Founded in 2004, H••••••• Equity Partners is the preferred capital partner to founders and owner-operators of lower, middle-market businesses in North America.
True partners for each step of your search fund journey.
W••• V•••••••, Early-stage teammates for consumer, health, and media startups.
G20 Ventures is the capital partner that helps new businesses grow with smart money, great storytelling, and the right connections.
Rhapsody Venture Partners invests in early stage, hard-tech innovations -- things like new materials, engineering innovations, chemistries, food tech -- helping bring them from the lab to market.
venture manager, reported GAV $285M across 42 vehicles
A••••• Ventures invests in breakthroughs that could avert catastrophic climate change. We partner with visionary founders for solutions.
Aiming to overcome technical and funding barriers in antibiotic development and ensuring a sustainable pipeline of new antibiotics to fight superbugs.
Providing Growth Equity Financing to Healthcare Companies for Over 30 years. Our B•••••-based venture capital investing philosophy is guided by our Core Company Investment Strategy, which accelerates the growth of a company through strategic consolidation within an industry. Focused on the “buy-and-build” strategy to support startups and entrepreneurs.
Impact the world with ESG impact investing and W••• E••••• P•••••••, investing in generational green, sustainable and clean energy companies.
Early-stage capital backing the next generation of frontier technology, critical infrastructure, and applied AI.
registered adviser; venture funds are 0% of 18 private funds
Founded in 2019, we’re privileged to partner with uniquely bold, disruptive early-stage companies that are advancing healthcare, generating strong returns, and saving lives. And we are having a bit of fun while doing it.
The official site of SoftBank Group Corp. (Chairman & CEO: Masayoshi Son). Discover our philosophy, investor relations, company information, business segments & group companies, and sustainability (ESG) initiatives.
One firm, 2 filing advisers on c•••••••••.com · C•••••••
venture manager, reported GAV $287M across 1 vehicles
venture manager, reported GAV $140M across 6 vehicles
B••••••• Ventures is a venture capital firm based in Boston, MA. We partner with Built Environment entrepreneurs and early-stage startups.
venture manager, reported GAV $254M across 2 vehicles
One firm, 2 filing advisers on n•••••••••.com · N•••• B•••••
venture manager, reported GAV $618M across 6 vehicles
Defining the future of business solutions.
N•••••• Partners is a multi-stage life sciences and healthcare venture capital firm based in Boston, MA.
T••••••• Ventures partners with entrepreneurs to solve meaningful problems across the Enterprise landscape through technology-enabled solutions that have lasting value in the networks, data, and platforms they create.
B••••••• is a collective of creative technologists advancing the art of building companies at the frontiers of technology and design.
no sworn venture fact yet (name or round mention only)
C••••.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to raise an awesome next round of financing.
One firm, 3 filing advisers on v•••••••••.com · V••• V•••••••
venture manager, reported GAV $640M across 4 vehicles
Standard of C••• Embracing Evidence. Increasing Success. Saving Lives. How We Go All-In With Entrepreneurs, We Bring C•••s to Life Learn More Our People Moving Medicine Forward Dr. Michael Aberman XenImmune Leveraging the robust immune response to target tumors like never before. Read Michael’s Story Dr. Milenko Cicmil Tasca Therapeutics Unlocking post-translational modification to expand […]
venture manager, reported GAV $100M across 8 vehicles
B•••: Investing at the intersection of the digital and physical worlds
The firm names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source is public either way.